Please assess the completion status of the following clinical trial:

Trial Title: Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients aged over 18 years, planned to undergoing elective laparoscopic surgery under general anesthesia~Exclusion Criteria:~* Obesity BMI over 30 kg/m2~* Impairment of renal or/and liver function~* Allergy to rocuronium, sugammadex~* (Familial) history of malignant hyperthermia~* Taking medicines which is affecting neuromuscular function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neostigmine (Type: ACTIVE_COMPARATOR): At the end of surgery, administrating neostigmine to participants according to the protocol below:~when train-of-four (TOF) 2-3, administrating neostigmine 50mcg/kg when TOF 4 with fade, administrating neostigmine 40mcg/kg when TOF 4 without fade, administrating neostigmine 20mcg/kg
- Sugammadex (Type: ACTIVE_COMPARATOR): At the end of surgery, administrating sugammadex to participants according to the protocol below:~when TOF=0 and post-tetanic count (PTC)=1 or more, administrating sugammadex 4mg/kg when TOF=1 or more, administrating sugammadex 2mg/kg when TOF 4 without fade, administrating neostigmine 20mcg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).